Curis (CRIS) Short-term Investments (2010 - 2024)
Curis (CRIS) reported Short-term Investments of $18.4 million for Q2 2024, down 57.94% on a YoY basis from $43.7 million in Q3 2023, and up 70.61% quarter-over-quarter from $10.8 million in Q1 2024.
Curis (CRIS) Short-term Investments (2010 - 2024) Analysis & Trends
Curis has reported Short-term Investments for 15 years, with the latest figure at $18.4 million in Q2 2024.
- For the quarter ending Q2 2024, Short-term Investments fell 57.94% year-over-year to $18.4 million; the trailing twelve-month figure through Jun 2024 stood at $18.4 million (down 57.94% YoY), and the FY2023 full-year result was $29.7 million, down 55.05% from the prior year.
- Short-term Investments for Q2 2024 stood at $18.4 million, up from $10.8 million in the prior quarter.
- The five-year high for Short-term Investments was $102.2 million in Q1 2022, with the low at $1000.0 in Q2 2020.
- Historically, Short-term Investments has averaged $47.7 million across 5 years, with a median of $44.0 million in 2023.
- Annual changes were most pronounced in 2020 — Short-term Investments slumped 99.35% — and 2021, when it jumped 7754300.0%.
- Curis' Short-term Investments stood at $38.9 million in 2020, then soared by 95.12% to $75.9 million in 2021, then declined by 13.06% to $66.0 million in 2022, then plunged by 55.05% to $29.7 million in 2023, then sank by 38.07% to $18.4 million in 2024.
- The last three Short-term Investments figures came in at $18.4 million (Q2 2024), $10.8 million (Q1 2024), and $29.7 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Curis | 8.37 Mn | -6.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 18.36 Mn |
| Mar 31, 2024 | 10.76 Mn |
| Dec 31, 2023 | 29.65 Mn |
| Sep 30, 2023 | 44.03 Mn |
| Jun 30, 2023 | 43.67 Mn |
| Mar 31, 2023 | 40.06 Mn |
| Dec 31, 2022 | 65.97 Mn |
| Sep 30, 2022 | 68.84 Mn |
| Jun 30, 2022 | 73.19 Mn |
| Mar 31, 2022 | 102.19 Mn |
| Dec 31, 2021 | 75.87 Mn |
| Sep 30, 2021 | 75.88 Mn |
| Jun 30, 2021 | 77.54 Mn |
| Mar 31, 2021 | 45.38 Mn |
| Dec 31, 2020 | 38.88 Mn |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 153,000.00 |
| Dec 31, 2019 | 5.11 Mn |
| Sep 30, 2019 | 6.65 Mn |
| Jun 30, 2019 | 153,000.00 |